{
  "story_id": "8ac2b2c04213509ca525fe76b2a108a8",
  "desk": "drm3",
  "revision": 1,
  "published_at": "2026-11-19T00:00:00.000Z",
  "content_hash": "6244776d5bf2b404c29e9ea076980296ca85027b3b13e3ca6cd26faa182a9431",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "Multiomics study identifies molecular axis linked to diabetic retinopathy",
    "dek": "Rat model proteomic/metabolomic analysis links myristic acid and thrombomodulin to diabetic retinopathy.",
    "prose": "In fully adjusted models, each one-point increase in Naples Prognostic Score was associated with 53.6% higher hazard of diabetic retinopathy (HR 1.54, 95% CI 1.30-1.82; p < 0.001). [^1]\n\nMultiomic joint analysis identified thrombomodulin (THBD) and myristic acid (MA) as candidate dysregulated molecules in diabetic retinopathy. [^2] Over 1440.4 person-years of follow-up with median 35.4 months duration, 156 participants (33.3%) developed incident diabetic retinopathy. [^3] This study used combined proteomics and metabolomics on rat retinal tissue to investigate diabetic retinopathy pathogenesis. [^4]\n\nDiabetic retinopathy is two times more frequent in patients with LADA compared to those with type 2 DM. [^5] High serum levels of glutamic acid decarboxylase antibody (GADA), poor glycemic control, and long duration of the disease may lead to diabetic retinopathy. [^6] The prevalence of DR in LADA patients ranged from about 10-26%, with the majority being mild non-proliferative DR. [^7]\n\nThe scientific evidence for complications of LADA, and especially for DR, is limited, since there are very few studies with small sample size. [^8]",
    "cited": "[{\"statement\":\"In fully adjusted models, each one-point increase in Naples Prognostic Score was associated with 53.6% higher hazard of diabetic retinopathy (HR 1.54, 95% CI 1.30-1.82; p < 0.001).\",\"source\":\"Frontiers\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-19T00:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Frontiers\"],\"url\":\"https://www.frontiersin.org/articles/10.3389/fnut.2026.1967340\"},{\"statement\":\"Multiomic joint analysis identified thrombomodulin (THBD) and myristic acid (MA) as candidate dysregulated molecules in diabetic retinopathy.\",\"source\":\"Frontiers\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-19T00:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Frontiers\"],\"url\":\"https://www.frontiersin.org/articles/10.3389/fendo.2026.1967569\"},{\"statement\":\"Over 1440.4 person-years of follow-up with median 35.4 months duration, 156 participants (33.3%) developed incident diabetic retinopathy.\",\"source\":\"Frontiers\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-19T00:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Frontiers\"],\"url\":\"https://www.frontiersin.org/articles/10.3389/fnut.2026.1967340\"},{\"statement\":\"This study used combined proteomics and metabolomics on rat retinal tissue to investigate diabetic retinopathy pathogenesis.\",\"source\":\"Frontiers\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-19T00:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"Frontiers\"],\"url\":\"https://www.frontiersin.org/articles/10.3389/fendo.2026.1967569\"},{\"statement\":\"Diabetic retinopathy is two times more frequent in patients with LADA compared to those with type 2 DM.\",\"source\":\"Nature\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-17T18:20:04.593Z\",\"publisher_count\":1,\"sources\":[\"Nature\"],\"url\":\"https://www.nature.com/articles/s41387-026-00472-4\"},{\"statement\":\"High serum levels of glutamic acid decarboxylase antibody (GADA), poor glycemic control, and long duration of the disease may lead to diabetic retinopathy.\",\"source\":\"Nature\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-17T18:20:04.593Z\",\"publisher_count\":1,\"sources\":[\"Nature\"],\"url\":\"https://www.nature.com/articles/s41387-026-00472-4\"},{\"statement\":\"The prevalence of DR in LADA patients ranged from about 10-26%, with the majority being mild non-proliferative DR.\",\"source\":\"Nature\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-17T18:20:04.593Z\",\"publisher_count\":1,\"sources\":[\"Nature\"],\"url\":\"https://www.nature.com/articles/s41387-026-00472-4\"},{\"statement\":\"The scientific evidence for complications of LADA, and especially for DR, is limited, since there are very few studies with small sample size.\",\"source\":\"Nature\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-11-17T18:20:04.593Z\",\"publisher_count\":1,\"sources\":[\"Nature\"],\"url\":\"https://www.nature.com/articles/s41387-026-00472-4\"}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": {
    "slice_hash": "b90c558c87a0581cddd04c8eb721dbc0306d8fc4408976c5585d7228f0d2f420",
    "cursor_from": "ingest:raw_newsroomfloor.stories:b90c558c87a0581c",
    "cursor_to": "ingest:raw_newsroomfloor.stories:b90c558c87a0581c",
    "view": "ingest:raw_newsroomfloor.stories",
    "view_version": "1",
    "row_count": 1,
    "hash_basis": "sha256 over the JSON array of {insertId, json} rows as received (normalized wire shape), computed before the BigQuery forward",
    "credits": 0.01,
    "price_per_100_rows_written": 1,
    "sig": "J358jtUZAgx9WELdE4Z6Yj5OytretpD_J4f_sPEXOnkEw680fugjwTRBFBJXJXJfbAs2MFLjTGv43IKKLF6cBA",
    "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
    "signer_path": "lakehouse/data-extract/v1",
    "alg": "Ed25519",
    "signed": true
  },
  "receipt_note": "the ingest door's signed receipt for this revision, verbatim as the door returned it",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "6068171dad9049f330d5561647ffad9b",
      "thread_id": "f160d9516fa3059fdd98045696012e3a",
      "thread_label": "Diabetic Retinopathy",
      "novelty": "UPDATE",
      "content_hash": "e89ddf96aba40f75ba4ed180ef87ec0a162f792b83fdf66121ddbcf45936d0d8",
      "compose": 3,
      "last_published_at": "2026-11-19T00:00:00.000Z",
      "read_receipt": {
        "slice_hash": "88a60e88b4b433a6abd1b39be604d9f09db6fe2a864e1b5c63ef5c859e7bf28a",
        "cursor_from": "eyJ0cyI6IjIwMjYtMTEtMThUMjE6NTM6MzguMDAwWiIsImlkIjoiMTM1ZTUyZmUzNDhmNWQ3OWQ3NzI0NTIzMjE2YWUyYmIiLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMTEtMTlUMDM6NTE6NTguMDAwMDAwWiIsImlkIjoiN2UxZjk0MzRhNjJkY2MxZDNmOTcwNzQ1ODEyZTE0ZDIiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 100,
        "window_days": 3,
        "bytes_scanned": 3577351,
        "credits": 8,
        "price_per_100_rows": 8,
        "sig": "VtX4HDc32Ha7kHpdOhOLilS3ywINUJs0G4fsvJoJTcItQQM8R52uyHBGpftLRSJGi-XmaV_2pIUBGJYQRj3CDw",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      },
      "landing": "air"
    },
    "written_at": "2026-11-19T21:57:31.884Z"
  },
  "cited_facts": [
    {
      "n": 1,
      "statement": "In fully adjusted models, each one-point increase in Naples Prognostic Score was associated with 53.6% higher hazard of diabetic retinopathy (HR 1.54, 95% CI 1.30-1.82; p < 0.001).",
      "source": "Frontiers",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.frontiersin.org/articles/10.3389/fnut.2026.1967340",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 2,
      "statement": "Multiomic joint analysis identified thrombomodulin (THBD) and myristic acid (MA) as candidate dysregulated molecules in diabetic retinopathy.",
      "source": "Frontiers",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.frontiersin.org/articles/10.3389/fendo.2026.1967569",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 3,
      "statement": "Over 1440.4 person-years of follow-up with median 35.4 months duration, 156 participants (33.3%) developed incident diabetic retinopathy.",
      "source": "Frontiers",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.frontiersin.org/articles/10.3389/fnut.2026.1967340",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 4,
      "statement": "This study used combined proteomics and metabolomics on rat retinal tissue to investigate diabetic retinopathy pathogenesis.",
      "source": "Frontiers",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.frontiersin.org/articles/10.3389/fendo.2026.1967569",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 5,
      "statement": "Diabetic retinopathy is two times more frequent in patients with LADA compared to those with type 2 DM.",
      "source": "Nature",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.nature.com/articles/s41387-026-00472-4",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 6,
      "statement": "High serum levels of glutamic acid decarboxylase antibody (GADA), poor glycemic control, and long duration of the disease may lead to diabetic retinopathy.",
      "source": "Nature",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.nature.com/articles/s41387-026-00472-4",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 7,
      "statement": "The prevalence of DR in LADA patients ranged from about 10-26%, with the majority being mild non-proliferative DR.",
      "source": "Nature",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.nature.com/articles/s41387-026-00472-4",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 8,
      "statement": "The scientific evidence for complications of LADA, and especially for DR, is limited, since there are very few studies with small sample size.",
      "source": "Nature",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.nature.com/articles/s41387-026-00472-4",
      "occurred_at": null,
      "published_at": null
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true. The dates on cited_facts (occurred_at, published_at) are the forge's, joined at read time; they are not part of the signed basis above."
}